126 related articles for article (PubMed ID: 18284408)
1. Sunitinib therapy in renal cell carcinoma.
O'Brien MF; Russo P; Motzer RJ
BJU Int; 2008 Jun; 101(11):1339-42. PubMed ID: 18284408
[No Abstract] [Full Text] [Related]
2. Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases.
Rini BI; Shaw V; Rosenberg JE; Kim ST; Chen I
Clin Genitourin Cancer; 2006 Dec; 5(3):232-4. PubMed ID: 17239278
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for renal cell carcinoma in patients with von Hippel-Lindau disease.
Tsimafeyeu I; Demidov L
J Cancer Res Ther; 2010; 6(4):575-7. PubMed ID: 21358107
[TBL] [Abstract][Full Text] [Related]
4. Molecularly targeted therapy in renal cell carcinoma: where do we go from here?
Rini BI
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1753-60. PubMed ID: 17181489
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery.
Silberstein JL; Millard F; Mehrazin R; Kopp R; Bazzi W; DiBlasio CJ; Patterson AL; Downs TM; Yunus F; Kane CJ; Derweesh IH
BJU Int; 2010 Nov; 106(9):1270-6. PubMed ID: 20394613
[TBL] [Abstract][Full Text] [Related]
6. Prolonged response to cytoreductive surgery and sunitinib in an elderly patient with synchronous multiple metastases from renal cell carcinoma.
Locatelli MC; Miedico A; D'Antona A; Longo G; Maggioni M; Maggioni A; Tombolini P; Tabiadon D
Tumori; 2010; 96(3):478-82. PubMed ID: 20845812
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant sunitinib effectiveness in T4 renal clear cell carcinoma: a case report.
Ricciardulli S; Del Biondo D; Cicero C; Leo G; Zeccolini G; Celia A
Urologia; 2015; 82(2):109-13. PubMed ID: 25050998
[TBL] [Abstract][Full Text] [Related]
8. Complete pathological response after sequential therapy with sunitinib and radiotherapy for metastatic clear cell renal carcinoma.
Venton G; Ducournau A; Gross E; Lechevallier E; Rochwerger A; Curvale G; Zink JV; Salas S; Deville JL
Anticancer Res; 2012 Feb; 32(2):701-5. PubMed ID: 22287766
[TBL] [Abstract][Full Text] [Related]
9. [Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma].
Miller K; Bergmann L; Albers P; Jäger E; Jakse G; Geschwend JE; Marschner N
Aktuelle Urol; 2007 Jul; 38(4):328-30. PubMed ID: 17647172
[TBL] [Abstract][Full Text] [Related]
10. Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib.
Fokt RM; Templeton A; Gillessen S; Ohlschlegel C; Schmid HP
Urol Int; 2009; 83(1):122-4. PubMed ID: 19641373
[TBL] [Abstract][Full Text] [Related]
11. Vascular Endothelial Growth Factor Receptor-Targeted Therapy in Succinate Dehydrogenase C Kidney Cancer.
Shuch B; Agochukwu N; Ricketts CJ; Vocke CD; Gautam R; Merino M; Linehan WM; Srinivasan R
J Clin Oncol; 2016 Mar; 34(9):e76-9. PubMed ID: 25024072
[No Abstract] [Full Text] [Related]
12. Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery.
Gorin MA; Ekwenna O; Soloway MS; Ciancio G
Urology; 2012 Feb; 79(2):e11. PubMed ID: 21676439
[TBL] [Abstract][Full Text] [Related]
13. Rapid involution of choroidal metastasis secondary to renal cell carcinoma with oral sunitinib.
Chin EK; Almeida DR; Sacher BA; Boldt HC
JAMA Ophthalmol; 2015 Jan; 133(1):109-10. PubMed ID: 25321845
[No Abstract] [Full Text] [Related]
14. Cytoreductive nephrectomy in the era of targeted molecular agents: is it time to consider presurgical systemic therapy?
Margulis V; Wood CG
Eur Urol; 2008 Sep; 54(3):489-92. PubMed ID: 18206292
[No Abstract] [Full Text] [Related]
15. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
Margulis V; Matin SF; Tannir N; Tamboli P; Swanson DA; Jonasch E; Wood CG
J Urol; 2008 Jul; 180(1):94-8. PubMed ID: 18485389
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant therapy for renal cancer].
Thibault F; Rixe O; Meric JB; Renard-Penna R; Boostan H; Mozer P; Comperat E; Richard F; Bitker MO
Prog Urol; 2008 Apr; 18(4):256-8. PubMed ID: 18501308
[TBL] [Abstract][Full Text] [Related]
17. Pre-surgical targeted molecular therapy in renal cell carcinoma.
Margulis V; Wood CG
BJU Int; 2009 Jan; 103(2):150-3. PubMed ID: 19007359
[TBL] [Abstract][Full Text] [Related]
18. Consolidative renal cell carcinoma metastatectomy for partial response after multitargeted tyrosine kinase inhibitor therapy.
Neill MG; Wei AC; Jewett MA
Urology; 2007 Jul; 70(1):178.e9-11. PubMed ID: 17656238
[TBL] [Abstract][Full Text] [Related]
19. Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.
Basille D; Andrejak M; Bentayeb H; Kanaan M; Fournier C; Lecuyer E; Boutemy M; Garidi R; Douadi Y; Dayen C
Ann Pharmacother; 2010 Feb; 44(2):383-6. PubMed ID: 20118139
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma: today's targeted therapies improving tomorrow's outcomes.
Biedrzycki BA
ONS News; 2006; 21(8 Suppl):21-2. PubMed ID: 16925136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
